OzmoCAP® capsules control the release of drug as it transits the gastro-intestinal (GI) tract, and now our customers can visualize this in dogs with matched x-ray imaging and PK sampling. FreeThink quickly develops OzmoCAP® capsules for studies in animals including a...
FreeThink participated in the AAPS Northeast Regional Discussion Group (NERDG) Annual Meeting, which was held in Queens, NY on March 31st. In addition to sponsoring the event, FreeThink exhibited and presented its latest technologies and innovations. Technology...
FreeThinkers Dr. Jennifer Chu and Dave Lucey enjoyed their participation in the 4th European Conference on Pharmaceutics held at the Palais des Congrés Exhibition and Convention Centre in Marseille on March 20–21. The FreeThink team participated in the exhibition, and...
OzmoCAP® was present at this year’s AAPS PharmSci 360 annual meeting, both in the booth and on the stage. Technology Development Lead Jennifer Chu, Ph.D., gave a presentation on the OzmoCAP® technology titled “Rapid Preclinical Assessment for Extended Release Drug...
OzmoCAP® will be at the AAPS PharmSci 360 annual meeting held in Boston, MA, from October 16 to 19. Come say hello! Technology Development Lead Jennifer Chu, Ph.D., will give a presentation on the OzmoCAP® technology: “Rapid Preclinical Assessment for Extended Release...
